The therapeutic landscape for non–small cell lung cancer (NSCLC) has been relatively stable since the 2016 approval of pembrolizumab, but results presented at the 2024 World Conference on Lung ...

In 2020, this disease was the cause of 1.8 million deaths and 18% of all cancer-related deaths. 1 Most lung cancers are classified as non–small cell lung cancer (NSCLC).

AI, Targeted Combinations Advance NSCLC Treatment Landscape. Martine Perez. April 09, 2025 . 0. ... Diseases & Conditions Non-Small Cell Lung Cancer (NSCLC) Treatment Protocols; ...

During June, investigators reported new data that has advanced the treatment landscape for lung cancer, including new FDA ...

Non-Small-Cell Lung Cancer (NSCLC) Pipeline Landscape Report 2024: Comprehensive Insights About 100+ Companies and 120+ Pipeline Drugs - ResearchAndMarkets.com March 06, 2024 08:48 AM Eastern ...

Recently, the Cancer Research Institute and Regeneron commissioned a survey to gather perspectives from U.S. oncologists on the advanced NSCLC treatment landscape and areas where they would like ...

Surgery is a standard initial treatment modality for patients with stage I and II non-small cell lung cancer (NSCLC). However, a better understanding of the current treatment landscape for early ...

Historically, non-small cell lung cancer (NSCLC) treatment involved three modalities: surgery, radiation therapy and chemotherapy. In the last two decades, the treatment landscape of NSCLC has ...

These medical advances, combined with a greater understanding of the treatment landscape, are paving the way for outcomes in unresectable Stage 3 NSCLC that are greatly improving compared to ...

This is especially important given how much the NSCLC treatment landscape has changed in recent years. “It is absolutely unbelievable how the treatment options have changed in the short 7 years ...

Depending upon the results of clinical trials, TIL therapy could change the treatment landscape of non–small cell lung cancer in patients who have progressed on first-line therapy with chemotherapy ...